ANDG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ANDG is a good buy right now for a beginner with a long-term horizon and $50,000-$100,000 to invest. The stock is trading near its current resistance area but the broader setup remains constructive, and I would rate it a Buy based on strong analyst support, improving price targets, and bullish moving averages. Since the user is impatient and wants an immediate decision rather than waiting for a perfect entry, I would buy now rather than delay. The main reason is that the stock has positive Wall Street momentum, no negative news flow, and technical trend support remains intact.
ANDG is in an overall bullish trend. The moving averages are aligned positively with SMA_5 above SMA_20 above SMA_200, which supports trend strength. RSI_6 at 65.586 is neutral-to-firm, showing the stock is not deeply overbought but is getting extended. MACD histogram is -0.0849 and still below zero, but it is negatively contracting, which can suggest downside momentum is easing. The stock closed at 38.13, just below R1 at 38.725, with pivot support at 36.647. This suggests the stock is holding a strong short-term range and has room to test the 40.009 resistance if momentum continues. Overall technicals are positive, though near-term upside may be somewhat capped unless it clears resistance.
UBS, Truist, Deutsche Bank, and Baird all lifted targets to the low-to-mid $40s, while maintaining Buy/Outperform views. Truist specifically cited second-quarter results as a public company that beat revenue and EBITDA consensus and highlighted continued M&A potential. Baird pointed to pricing power and strong productivity. The stock also showed a favorable modeled trend with a 60% chance of modest gains over the next day, week, and month. There is no negative news flow in the latest week, and hedge fund and insider trading trends are neutral rather than bearish.
There is no recent news catalyst to drive a fresh breakout, so near-term momentum may slow without a new event. MACD remains below zero, which means the trend is not fully confirmed by momentum yet. Morgan Stanley remains cautious with an Equal Weight rating and a much lower target than some peers, showing that Wall Street is not unanimously bullish. The stock is also approaching resistance near 38.725 and 40.009, which may limit immediate upside.
The latest quarter was the second quarter as a public company, and analyst commentary says Andersen Group delivered revenue and EBITDA above consensus again. Truist said the company beat expectations and expects continued M&A to expand scale and synergies. Baird also described the results as showing strong accelerating fundamentals and conservative guidance, which points to healthy growth momentum. Even though the raw financial snapshot was unavailable, the quarter appears to have shown strong top-line and profitability trends.
Analyst sentiment is clearly positive overall. Recent price target revisions were upward across several firms: UBS raised target to $42 from $34 and keeps Buy; Truist raised target to $42 from $32 and keeps Buy; Deutsche Bank raised target to $41 from $30 and keeps Buy; Baird raised target to $44 from $42 and keeps Outperform. Morgan Stanley was more cautious, raising target to $27 from $24 while keeping Equal Weight. The pros view is that the company is executing well, beating revenue and EBITDA expectations, and benefiting from pricing power and productivity. The cons view is that not every analyst is fully convinced, as shown by the lower Morgan Stanley target and neutral stance. Overall, Wall Street sentiment is bullish.
